Abstract
The current study's objective is to directly compress a Zopiclone rapid release tablet and assess it. The superdisintegrants (crospovidone, croscarmellose sodium, fenugreek) were used to hasten drug release from tablets. The prepared tablets pre-compression, post-compression characteristics were scrutinised. The interactions between the medication excipients were investigated using FTIR. The research shows that direct compression F3 formulations had a faster drug release of 100.05% over a 45-minute period than other Zopiclone formulations, which had lower dissolving rates when utilising Crospovidone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
